مقاله‌های دارای تعهدات انتشار عمومی - Katsiaryna Bykovبیشتر بدانید
جای دیگری دردسترس نیست: ۵
A population-based cohort defined risk of hyperkalemia after initiating SGLT-2 inhibitors, GLP1 receptor agonists or DPP-4 inhibitors to patients with chronic kidney disease …
EL Fu, J Mastrorilli, K Bykov, DJ Wexler, A Cervone, KJ Lin, E Patorno, ...
Kidney International 105 (3), 618-628, 2024
تعهدات: US National Institutes of Health, Netherlands Organisation for Scientific …
A multi-modal approach to evaluate the impact of risk evaluation and mitigation strategy (REMS) programs
A Sarpatwari, M Mitra-Majumdar, K Bykov, J Avorn, S Woloshin, ...
Drug Safety 44, 743-751, 2021
تعهدات: US National Institutes of Health, Arnold Ventures LLC
Risk of fall or fracture with concomitant use of prescription opioids and other medications in osteoarthritis patients
NF Khan, K Bykov, JN Katz, RJ Glynn, SM Vine, SC Kim
Pharmacoepidemiology and drug safety 33 (3), e5773, 2024
تعهدات: US National Institutes of Health
Trends in Use and Evidence of Adherence to Risk Evaluation and Mitigation Strategy Pregnancy Testing Requirements for Thalidomide, Lenalidomide, and Pomalidomide in the USA …
M Mahesri, A Sarpatwari, KF Huybrechts, J Lii, SB Lee, GA Toyserkani, ...
Drug Safety 47 (9), 909-919, 2024
تعهدات: Arnold Ventures LLC
Fracture in Association with Anticoagulant Therapy in Patients with Chronic Kidney Disease and Atrial Fibrillation
NF Khan, SC Kim, SB Lee, K Bykov, JM Paik
Clinical Journal of the American Society of Nephrology, 10.2215, 2024
تعهدات: US National Institutes of Health
جای دیگری دردسترس است: ۲۳
Persistent opioid use following cesarean delivery: patterns and predictors among opioid-naïve women
BT Bateman, JM Franklin, K Bykov, J Avorn, WH Shrank, TA Brennan, ...
American journal of obstetrics and gynecology 215 (3), 353. e1-353. e18, 2016
تعهدات: US National Institutes of Health
Patterns and predictors of persistent opioid use following hip or knee arthroplasty
SC Kim, N Choudhry, JM Franklin, K Bykov, M Eikermann, J Lii, ...
Osteoarthritis and cartilage 25 (9), 1399-1406, 2017
تعهدات: US National Institutes of Health
Association of gabapentinoids with the risk of opioid-related adverse events in surgical patients in the United States
K Bykov, BT Bateman, JM Franklin, SM Vine, E Patorno
JAMA network open 3 (12), e2031647-e2031647, 2020
تعهدات: US National Institutes of Health
Association of fluoroquinolones with the risk of aortic aneurysm or aortic dissection
C Gopalakrishnan, K Bykov, MA Fischer, JG Connolly, JJ Gagne, ...
JAMA internal medicine 180 (12), 1596-1605, 2020
تعهدات: US National Institutes of Health
Thiazolidinediones and Parkinson disease: a cohort study
JG Connolly, K Bykov, JJ Gagne
American journal of epidemiology 182 (11), 936-944, 2015
تعهدات: US National Institutes of Health
Prevalence of avoidable and bias‐inflicting methodological pitfalls in real‐world studies of medication safety and effectiveness
K Bykov, E Patorno, E D’Andrea, M He, H Lee, JS Graff, JM Franklin
Clinical Pharmacology & Therapeutics 111 (1), 209-217, 2022
تعهدات: US National Institutes of Health
Trends in the use of oral anticoagulants for adults with venous thromboembolism in the US, 2010-2020
GS Iyer, H Tesfaye, NF Khan, H Zakoul, K Bykov
JAMA Network Open 6 (3), e234059-e234059, 2023
تعهدات: US National Institutes of Health, Patient-Centered Outcomes Research Institute
Association of type of oral anticoagulant dispensed with adverse clinical outcomes in patients extending anticoagulation therapy beyond 90 days after hospitalization for venous …
A Pawar, JJ Gagne, C Gopalakrishnan, G Iyer, H Tesfaye, G Brill, K Chin, ...
Jama 327 (11), 1051-1060, 2022
تعهدات: Patient-Centered Outcomes Research Institute
Trends in utilization of prescribed controlled substances in US commercially insured adults, 2004-2019
K Bykov, M He, JJ Gagne
JAMA Internal Medicine 180 (7), 1006-1008, 2020
تعهدات: US National Institutes of Health
Glucose‐lowering medications and the risk of cancer: a methodological review of studies based on real‐world data
K Bykov, M He, JM Franklin, EM Garry, JD Seeger, E Patorno
Diabetes, Obesity and Metabolism 21 (9), 2029-2038, 2019
تعهدات: US National Institutes of Health
Comparison of self-controlled designs for evaluating outcomes of drug–drug interactions: simulation study
K Bykov, JM Franklin, H Li, JJ Gagne
Epidemiology 30 (6), 861-866, 2019
تعهدات: US National Institutes of Health
A unified framework for classification of methods for benefit-risk assessment
M Najafzadeh, S Schneeweiss, N Choudhry, K Bykov, KH Kahler, ...
Value in Health 18 (2), 250-259, 2015
تعهدات: Canadian Institutes of Health Research
Comparative effectiveness and safety of oral anticoagulants by dementia status in older patients with atrial fibrillation
KJ Lin, DE Singer, K Bykov, LG Bessette, JM Mastrorilli, A Cervone, ...
JAMA network open 6 (3), e234086-e234086, 2023
تعهدات: US National Institutes of Health
Bias in case‐crossover studies of medications due to persistent use: a simulation study
K Bykov, SV Wang, J Hallas, A Pottegård, M Maclure, JJ Gagne
Pharmacoepidemiology and drug safety 29 (9), 1079-1085, 2020
تعهدات: US National Institutes of Health
Risk of opioid overdose associated with concomitant use of oxycodone and selective serotonin reuptake inhibitors
I Yunusa, JJ Gagne, K Yoshida, K Bykov
JAMA Network Open 5 (2), e220194-e220194, 2022
تعهدات: US National Institutes of Health
اطلاعات انتشارات و تأمین بودجه به‌طورخودکار توسط برنامه رایانه‌ای تعیین می‌شود.